cost-utility analysis - Globe Thesis

Keyword [cost-utility analysis] Result: 41 - 58 \| Page: 3 of 3
41.	Pharmacoeconomic Evaluation Of Rosuvastatin In Primary Prevention Of Cardiovascular Disease
42.	Cost-utility Analysis Of Neonatal Hepatitis B Vaccine Immunization Planning Strategies In Beijing From 1992 To 2013
43.	A Cross-Sectional Study On Genitial Chlamydia Trachomatis Infection Among Population-Based Fertile Women And The Cost-Effectiveness Analysis Of Screening
44.	Effect Of Hearing Intervention On The Elderly With Cognitive Frailty And The Health Economic Evaluation Of The Intervention
45.	Sexual Behavior Changes And Medical Costs With Markov Analysis Of Rectal Swab Self-collection For Testing Chlamydia Trachomatis And Neisseria Gonorrhoeae In HIV-positive Men Who Have Sex With Men
46.	Pharmacoeconomic Evaluation Of Hypertension Drugs Based On Markov Model
47.	Economic Evaluation Of Abatacept Vs Adalimumab For The Treatment Of Patients With Moderate To Severe Rheumatoid Arthritis
48.	Cost-utility Analysis Of Atezolizumab Plus Bevacizumab Versus Sorafenib As First-line Therapy In Unresectable Or Metastatic Hepatocellular Carcinoma
49.	The Construction And Validation Of Evaluation Index System For Post-Marketing Chinese Patent Medicine Value With MCDA Model
50.	Cost-utility Analysis Of Different Venous Access In Cancer Patients Based On Decision Tree Model
51.	Evaluation Of The Value Of Selexipag In The Treatment Of Pulmonary Arterial Hypertension
52.	A Comprehensive Evaluation Of Three Original ARB/CCB Combinations For The Treatment Of Essential Hypertension With Poor Monotherapy Control
53.	A Cost-utility Analysis Of IGlarLixi Versus IDegAsp In The Treatment Of Type Ⅱ Diabetes Patients In China
54.	Interferon Gamma Release Assay For Diagnosis And Screening Of Tuberculosis Infection In Patients With Rheumatic Diseases:Systematic Review And Health Economics Evaluation
55.	Economic Evaluation Of Ensartinib For Patients With Anaplastic Lymphoma Kinase-positive Non-small-cell Lung Cancer In China
56.	Pharmaco-economic Evaluation Of Sintilimab For First-line Treatment Of Advanced Non-small Cell Lung Cancer
57.	Pharmacoeconomic Evaluation Of Carfilzomib In The Treatment Of Newly Diagnosed Multiple Myeloma
58.	Development And Health Economic Evaluation Of Cervical Cancer Screening Strategy Among Rural Women In Hubei Province
<<First <Prev Next> Last>> Jump to